Teva, Allergan settle Rhode Island opioid suit for $107M: 3 notes

Allergan and Teva Pharmaceuticals have settled allegations that they helped fuel Rhode Island's opioid epidemic, state Attorney General Peter Neronha said March 21.

Three notes:

1. As part of the settlement, the drugmakers will pay the state a combined $28.5 million in cash over the next 13 years.

2. They'll also give Rhode Island 1 million doses of naloxone, which can be used to reverse the effects of an opioid overdose, and 67,000 30-pill bottles of Suboxone, a medication used to treat opioid use disorder, in various doses for free over the next 10 years.

3. The deal results in a combined settlement value of $107 million. 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars